Klin Monbl Augenheilkd 2008; 225(9): 779-790
DOI: 10.1055/s-2008-1027515
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Netzhautablösung im Kindesalter: Differenzialdiagnose und aktuelle Therapieoptionen

Retinal Detachment in Children: Differential Diagnosis and Current TherapyP. Meier1
  • 1Universität Leipzig, Klinik und Poliklinik für Augenheilkunde
Weitere Informationen

Publikationsverlauf

Eingegangen: 23.1.2008

Angenommen: 8.4.2008

Publikationsdatum:
29. August 2008 (online)

Zusammenfassung

Eine Ablatio retinae tritt im Kindesalter im Vergleich zum Erwachsenenalter relativ selten auf, nur ca. 3,2 – 6,6 % aller Netzhautablösungen werden bei Kindern diagnostiziert. Risikofaktoren für das Auftreten einer kindlichen Netzhautablösung sind ein Bulbustrauma, assoziierte Augapfelerkrankungen, Myopie und Retinopathia praematurorum (ROP) im Stadium 4 und 5 und im Spätstadium. Darüber hinaus werden sog. idiopathisch auftretende Netzhautablösungen beobachtet. Diese Kinder weisen keinerlei okuläre oder systemische Auffälligkeiten auf. Assoziierte Augapfelerkrankungen umfassen hereditäre vitreoretinale Erkrankungen (z. B. Morbus Stickler, X-chromosomale Retinoschisis, Marfan-Syndrom, familiär-exsudative Vitreoretinopathie), Malformationen (z. B. persistierender hyperplastischer primärer Vitreus [PHPV], Netzhaut-Aderhaut-Kolobom) und Netzhautablösungen infolge von Augenoperationen, vorrangig Linsenoperationen. Selten treten Netzhautablösungen in dieser Altersgruppe im Rahmen einer Uveitis oder bei Morbus Coats auf. Oftmals wird die Diagnose einer Netzhautablösung erst in einem Spätstadium gestellt, wenn bereits ausgeprägte Proliferationen ausgebildet sind. Kinder mit Risikofaktoren sollten deshalb einer intensiven augenärztlichen Kontrolle unterzogen werden. Trotz adäquater Folgebehandlung einer kindlichen Netzhautablösung resultieren schlechtere funktionelle und anatomische Ergebnisse im Vergleich zur Therapie einer Ablatio retinae im Erwachsenenalter. Eine Verbesserung der Prognose ist nur durch Ätiologie-spezifische Behandlungskonzepte denkbar. So gibt es Einzelberichte über den therapeutischen Einsatz von anti-angiogenen Substanzen bei ROP. Allerdings benötigen wir weitere Erkenntnisse über mögliche Nebenwirkungen und Komplikationen einer Therapie mit VEGF-Inhibitoren bei Frühgeborenen, da die unreife Netzhaut nicht der Retina eines Erwachsenen gleicht. Eine Therapie mit Anti-VEGF-Substanzen bei Frühgeborenen ist ohne kontrollierte Studien nicht zu empfehlen.

Abstract

The number of retinal detachments in children is very low in comparison to the number of retinal detachments in adults, only 3.2 – 6.6 % occur in children. The main predisposing factors are trauma, associated conditions, myopia and retinopathy of prematurity (ROP) i. e., stage 4 and 5 and late stage of ROP. Furthermore, retinal detachment in children can be idiopathic. These eyes are not associated with any identified ocular or systemic comorbidity. Associated conditions include hereditary vitreoretinal disorders (e. g., morbus Stickler, X-linked juvenile retinoschisis, Marfan syndrome, familiär exsudative vitreoretinopathy), malformations (e. g., persistent hyperplastic primary vitreous, coloboma) and retinal detachment following cataract surgery. In a few cases retinal detachment is caused by uveitis and by Coats disease. Delayed presentation and proliferative vitreoretinopathy are a common problem and in most eyes primary pars plana vitrectomy is necessary. It is important to perform consequent postoperative follow-up. The functional and anatomic outcomes of retinal detachment in children are less successful than in adults. Further surgical innovations and aetiology-specific treatment strategies are required to improve the outcome in this group. Recent results show that the intravitreal use of VEGF inhibitors to treat proliferative retinopathy (ROP) in children is effective, but we need further information about safety and side-effects.

Literatur

  • 1 Abeysiri P, Bunce C, da Cruz L. Outcomes of surgery for retinal detachment in patients with Stickler syndrome: a comparison of two sequential 20-year cohorts.  Graefe’s Arch Clin Exp Ophthalmol. 2007;  245 1633-1638
  • 2 Amin H I, McDonald H R, Han D P. et al . Vitrectomy update for macular traction in ocular toxocariasis.  Retina. 2000;  20 80-85
  • 3 Ang A, Poulson A V, Goodburn S F. et al . Retinal detachment and prophylaxis in type 1 Stickler syndrome.  Ophthalmology. 2008;  115 164-168
  • 4 Alexandrakis G, Scott I U, Flynn H W Jr. et al . Viusal acuity outcomes with and without surgery in patients with persistent fetal vasculature.  Ophthalmology. 2000;  107 1068-1072
  • 5 Arbeitsgruppe zur Erstellung von Leitlinien zur ärztlichen Screening-Untersuchung von Frühgeborenen auf Initiative der Retinologischen Gesellschaft, in Abstimmung mit der Deutschen Ophthalmologischen Gesellschaft, dem Berufsverband der Augenärzte Deutschlands und der Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin . Augenärztliche Screening-Untersuchung von Frühgeborenen.  Ophthalmologe. 1999;  96 257-263
  • 6 Asaria R HY, Kon C H, Bunce C. et al . Adjuvant 5- fluorouracil and Heparin prevents proliferative vitreoretinopathy.  Ophthalmology. 2001;  108 1179-1183
  • 7 Bosch-Driessen L H, Karimi S, Stilma J S. et al . Retinal detachment in ocular toxoplasmosis.  Ophthalmology. 2000;  107 36-40
  • 8 Blankenship G W. Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases.  Graefes Arch Clin Exp ophthalmol. 1989;  227 565-568
  • 9 Bradley J, Ju M, Robinson G S. Combination therapy for the treatment of ocular neovascularization.  Angiogenesis. 2007;  10 141-148
  • 10 Butler T KH, Kiel A W, Orr G M. Anatomical and viusal outcome of retinal detachment surgery in children.  Br J Ophthalmol. 2001;  85 1437-1439
  • 11 Capone A, Trese M. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments.  Ophthalmology. 2001;  108 2068-2070
  • 12 Campochiaro P A, Hackett S F, Conway. Retinoic acid promotes densitydependent growth arrest in human retinal pigment epithelial cells.  Invest Ophthalmol Vis Sci. 1991;  32, 65-72
  • 13 Chang P Y, Yang C M, Yang C H. et al . Clinical and surgical outcomes of pediatric rhegmatogenous retinal detachment in Taiwan.  Am J Ophthalmol. 2005;  139 1067-1072
  • 14 Chen S N, Jiunn-Feng H, Te-Cheng Y. Pediatric rhegmatogenous detachment in Taiwan.  Retina. 2006;  26 410-416
  • 15 Chung E J, Kim J H, Ahn H S Koh HJ. Combination of laser photocoagulation and intravitreal bevacizumab for aggressive zone I retinopathy of prematurity.  Graefes Arch Clin Exp Ophthalmol. 2007;  245 1727-1730
  • 16 Chow D R, Ferrone P J, Trese M T. Refractive changes associated with scleral buckling and division in retinopathy of prematurity.  Arch Ophthalmol. 1998;  116 1446-1448
  • 17 Cryotherapy for retinopathy of prematurity cooperative group (CRPCG) . Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results.  Arch Ophthalmol. 1988;  106 471-479
  • 18 Cusick M, Charles M K, Agron E. et al . Anatomical and visual results of vitreoretinal surgery for stage 5 retinopathy of prematurity.  Retina. 2006;  26 729-735
  • 19 Daniels S A, Coonley K G, Yoshizumi M O. Taxol treatment of experimental proliferative vitreoretinopathy.  Graefes Arch Clin Exp Ophthalmol. 1990;  228 513-516
  • 20 Dotrelova D, Karel I, Clupkova E. Retinal detachment in Marfan’s syndrome.  Retina. 1997;  17 390-396
  • 21 Drass A B, Trese M T. Surgical results of persistent hyperplastic primary vitrous.  Ophthalmology. 1999;  106 280-284
  • 22 Early Treatment for ROP Study (ETROP) . Revised indications for the treatment of retinopathy of prematurity.  Arch Ophthalmol. 2003;  121 1684-1696
  • 23 Farr A K, Hairston R J, Humayun M U. Open globe injuries in children: a retrospective analysis.  J Ped Ophthalmol Strab. 2001;  38 72-77
  • 24 Ferrone P J, McCuen B W, Juan de E. et al . The efficacy of silicone oil for complicated retinal detachments in the pediatric population.  Arch Ophthalmol. 1994;  112 773-777
  • 25 Ferrone P J, Trese M T, Lewis H. Vitreoretinal surgery for complications of congenital retinoschisis.  Am J Ophthalmol. 1997;  123 742-747
  • 26 Freeman H M. Giant Retinal Tears. Tasman W, Jaeger EA Duane’s Clinical Ophthalmology. Vol. 6 Philadelphia, New York; Lippincott-Raven 1996: 1-11
  • 27 Freeman H M. Update on the Stickler syndrome. Vitreoretinal update 1999.  Orlando American Academy of Ophthalmology. 1999;  1 1-40
  • 28 Fuchino Y, Hayashi H, Kono T. et al . Long-trem follow-up of visual acuity in eyes with stage 5 retinopathy of prematurity after closed vitrectomy.  Am J Ophthalmol. 1995;  120 308-316
  • 29 George N DL, Yates J, Bradshaw K. et al . Infantile presentation of X linked retinoschisis.  Br J Ophthalmol. 1995;  114 274-280
  • 30 George N DL, Yates J RW, Moore A T. Clinical Features in affected males with X-linked Retinoschisis.  Arch Ophthalmol. 1996;  114 274-280
  • 31 Gilbert W S, Quinn M K, Dobson V. et al . Partial retinal detachment at 3 months after threshold retinopathy of prematurity. Long-term structural and functional outcome. Multicenter trial of cryotherapy for retinopathy of prematurity cooperative group.  Arch Ophthalmol. 1996;  114 1085-1091
  • 32 Glazer L C, Maguire A, Blumenkranz M S. et al . Improved treatment of familial exsudative vitreoretinopathy in children.  Am J Ophthalmol. 1995;  120 471-479
  • 33 Goffstein R, Burton T C. Differentiating traumatic from non-traumatic retinal detachments.  phthalmology. 1982;  89 361-368
  • 34 Gonzales C R, Boshra J, Schwartz S D. 25-gauge pars plicata vitrectomy for stage 4 and 5 retinopathy of prematurity.  Retina. 2006;  26 42-46
  • 35 Gopal L, Badrinath S S, Sharma T. et al . Surgical management of retinal detachment related to coloboma of the choroid.  Ophthalmology. 1998;  105 804-809
  • 36 Haimann M H, Burton T C, Brown C K. Epidemiology of retinal detachment.  Arch Ophthalmol. 1982;  100 289-292
  • 37 Häring G, Wiechens B. Long-term results after scleral buckling surgery in uncomplicated juvenile retinal detachment without proliferative vitreoretinopathy.  Retina. 1998;  18 501-505
  • 38 Hartnett M E. Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity.  Retina. 2003;  23 322-329
  • 39 Hartnett M E, Maguluri S, Thompson H W. et al . Comparsion of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity.  Retina. 2004;  24 753-757
  • 40 Hartnett M E. Features associated with surgical outcome in patients with stage 4 and 5 retinopathy of prematurity.  Retina. 2006;  23 322-329
  • 41 Heidenkummer H P, Kampik A. Experimental evaluation of in vitro stability of purified polydimethylsiloxanes (silicone oil) in viscosity ranges from 1000 to 5000 centistokes.  Retina. 1992;  12 (Suppl) 28-32
  • 42 Hellstrom A, Perruzzi C, Engstrom E. et al . Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity.  Proc Natl Acad Sci USA. 2001;  98 5804-5808
  • 43 Ikeda T, Fujikado T, Tano Y. et al . Vitrectomy for rhegmatogenous or tractional retinal detachment with familial exudative vitreoretinopathy.  Ophthalmology. 1999;  106 1081-1085
  • 44 Ishida S, Usui T, Yamashiro K. et al . VEGF164-mediated inflammation is required for pathological, but not physiological, ischemiainduced retinal neovascularization.  J Exp Med. 2003;  198 483-489
  • 45 Jandeck C, Kellner U, Foerster M H. Späte retinale Komplikationen bei Frühgeborenen mit regressiven Veränderungen.  Klin Monatsbl Augenheilkd. 2004;  221 96-100
  • 46 Juan E Jr, Noorily de S. Retinal detachment in infants. Ryan SJ, Glaser BM Retina St Louis, Baltimore, Boston, Chicago, London, Madrid, Philadelphia, Sydney, Toronto; Mosby 1994: 2499-2521
  • 47 Kaiser R S, Trese M, Williams G A. et al . Adult retinopathy of prematurity: Outcome of rhegmatogenous retinal detachment and retinal tears.  Ophthalmology. 2001;  108 1647-1653
  • 48 Kerkhoff F T, Lamberts Q J, Biesen P R. et al . Rhegmatogenous retinal detachment and uveitis.  Ophthalmology. 2003;  110 427-431
  • 49 Kirchhoff van den B, Völcker H E, Naumann G OH. Glaskörper. Naumann GOH Pathologie des Auges. 2. Aufl Berlin, Heidelberg, New York; Springer 1997: 955-994
  • 50 Kleinstein R N, Jones L A, Hullett S. et al . Collaborative longitudital evaluation of ethnicity in children.  Arch Ophthalmol. 2003;  121 1141-1147
  • 51 Kocak N, Saatci A O, Ilhan H D. et al . Pediatric silicone oil surgery.  J Pediatr Ophthalmol Strabismus. 2006;  43 353-357
  • 52 Kuhn F, Maisiak R, Mann L. et al . The Ocular Trauma Score (OTS).  Ophthalmol Clin North Am. 2002;  15 163-165
  • 53 Laatikainen L, Tarkkanen A, Harju H. Netzhautablösung bei Kindern und Jugendlichen.  Klin Mbl Augenheilk. 1984;  185 12-16
  • 54 Lakhanpal R R, Sun R L, Albini T A. et al . Viusal outcomes after 3-Port lens-sparing vitrectomy in stage 4 retinopathy of prematurity.  Arch Ophthalmol. 2006;  124 675-679
  • 55 Lakhanpal R R, Sun R L, Albini T A. et al . Anatomical success rate after primary three-port lens-sparing vitrectomy in stage 5 retinopathy of prematurity.  Retina. 2006;  26 724-728
  • 56 Lakhanpal R R, Fortun J A, Chan-Kai B. et al . Lensectomy and vitrectomy with and without intravitreal triamcinolone acetonide for vascularly active stage 5 retinal detachments in retinopathy of prematurity.  Retina. 2006;  26 736-740
  • 57 Lee R WJ, Mayer E J, Markham R H. The aetiology of paediatric rhegmatogenous retinal detachment : 15 years experience.  Eye. 2008;  22 636-640
  • 58 Leiba A, Oliver M, Pollack A. Prophylactic laser photocoagulation in Stickler syndrome.  Eye. 1996;  10 701-708
  • 59 Lemor M, Yeo J H, Glaser B M. Oral Colchicin for the treatment of experimental traction retinal detachmnet.  Arch Ophthalmol. 1986;  104 1226-1229
  • 60 Lin L L, Shih Y, Tsai C. et al . Epidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995.  Optom Vis Sci. 1999;  76 275-281
  • 61 Loewenstein A, Juan E Jr. Pediatric ocular trauma. Alfaro DV, Liggett PE Vitreoretinal surgery of the injured eye Philadelphia; Lippincott-Raven 1999: 289-300
  • 62 Loewenstein de A, Barequet I, Juan de E. et al . Retinal detachment in Marfan syndrome.  Retina. 2000;  20 358-363
  • 63 Machemer R. Late traction detachment in retinopathy of prematurity or ROP-like cases.  Graefe’s Arch Clin Exp Ophthalmol. 1993;  231 389-394
  • 64 MacRae M E, Patel D V, Richards A J. et al . Type 1 Stickler syndrome: a histological and ultrastructural study of an untreated globe.  Eye. 2006;  20 1061-1067
  • 65 Maguire A M, Green W R, Michels R G. Recovery of intraocular Toxacara canis by pars plana vitrectomy.  Ophthalmology. 1990;  97 675-680
  • 66 Maguire A M, Trese M T. Lens-sparing vitreoretinal surgery in infants.  Arch Ophthalmol. 1992;  110 284-286
  • 67 Meier P, Wiedemann P. Vitreoretinale Chirurgie bei Kindern.  Ophthalmologe. 1999;  96 536-554
  • 68 Meier P, Wiedemann P. Surgical aspects of vitreoretinal disease in children. 4th ed. Ryan SJ Retina Elsevier Mosby 2005 3 Chapter 145: 1-22
  • 69 Mingels A, Hudde T, Heinz C. et al . Visusmindernde Komplikationen bei Uveitis im Kindesalter.  Ophthalmologe. 2005;  5 477-484
  • 70 Millsap C M, Peyman G A, Ma P E. et al . The surgical management of retinopathy of prematurity using a perfluorcarbon liquid.  Int Ophthalmol. 1994;  18 97-100
  • 71 Mintz-Hittner H A, O’Malley R E, Kretzer F L. Long-term form identification vision after early, closed, lensectomy-vitrectomy for stage 5 retinopathy of prematurity.  Ophthalmology. 1997;  104 454-459
  • 72 Mittra R A, Huynh L T, Ruttum M S. et al . Visual outcomes following lensectomy and vitrectomy for combiened anterior and posterior persistent hyperplastic primary vitreous.  Arch Ophthalmol. 1998;  116 1190-1194
  • 73 Moisseiev J, Vidne O, Treister G. Vitrectomy and silicone oil injection in pediatric patients.  Retina. 1998;  18 221
  • 74 Ohno-Matsui K, Hirose A, Yamamoto S. et al . Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment.  Am J Pathol. 2002;  160 711-719
  • 75 Pendergast S D, Trese M T. Familial exsudative vitreoretinopathy.  Ophthalmology. 1998;  105 1015-1023
  • 76 Penn J S, Rajaratnam V S, Collier R J. et al . The effect of an angiostatic steroid on neovascularisation in a rat model of retinopathy of prematurity.  Invest Ophthalmol Vis Sci. 2001;  42 283-290
  • 77 Prenner J L, Capone A, Trese M. Visual outcomes after lens-sparing vitrectomy for stage 4 retinopathy of prematurity.  Ophthalmology. 2004;  111 2271-2273
  • 78 Pulido J S, Gupta S, Folk J C. et al . Perforating BB gun injuries of the globe.  Ophthalmic Surg Lasers. 1997;  28 625-632
  • 79 Quinn G E, Dobson V, Barr C C. et al . Cryotherapy for Retinopathy of prematurity Cooperative Group. Visual acuity of eyes after vitrectomy for retinopathy of prematurity.  Ophthalmology. 1996;  103 595-600
  • 80 Quiram P A, Capone A. Current understanding and management of retinopathy of prematurity.  Curr Opin Ophthalmol. 2007;  18 228-234
  • 81 Regillo C D, Tasman W S, Brown G C. Surgical management of Complications associated with X-linked Retinoschisis.  Arch Ophthalmol. 1993;  111 1080-1086
  • 82 Ricci B, Santo A, Ricci F. et al . Scleral buckling surgery in stage 4 retinopathy of prematurity.  Graefe’s Arch Clin Exp Ophthalmol. 1996;  234 38-41
  • 83 Ridley M E, Shields J A, Brown G C. et al . Coats’ disease. Evaluation of management.  Ophthalmology. 1982;  89 1381-1387
  • 84 Rodriguez F, Lewis H. Vitreoretinal surgery and silicone oil injection for severe penetrating ocular trauma in children.  Ophthalmology. 1991;  98 257
  • 85 Rosenfeld P J, Flynn H W, McDonald H R. et al . Outcomes of vitreoretinal surgery in patients with X-linked retinoschisis.  Ophthalmic Surg Lasers. 1998;  29 190-197
  • 86 Rostomian K, Thach A B, Isfahani A. et al . Open globe injuries in children.  J AAPOS. 1998;  2 234-238
  • 87 Rotschild T, Nandgaonkar B N, Higgens Y K. Dexamethasone reduces oxygen induced retinopathy in a mouse model.  Pediatr Res. 1999;  46 94-100
  • 88 Rumelt S, Sarrazin L, Averbuukh E. et al . Paediatric vs adult retinal detachment.  Eye. 2007;  21 1473-1478
  • 89 Sadeh A D, Dotan G, Brecha R. et al . Characteristics and outcomes of paediatric rhegmatogenous retinal detachment treated by segmental scleral buckling plus an encircling element.  Eye. 2001;  15 31-33
  • 90 Sarrazin L, Averbukh E, Halpert M. et al . Traumatic pediatric retinal detachment: A comparsion between open and closed globe injuries.  Am J Ophthalmol. 2004;  137 1042-1049
  • 91 Sasaki K, Ideta H, Yonemoto J. et al . Epidemiologic characteristics of rhegmatogenous retinal detachment in Kumanoto, Japan.  Graefe’s Arch Clin Exp Ophthalmol. 1995;  233 772-776
  • 92 Schmidt-Erfurth U, Lucke K. Vitreoretinal surgery in advanced Coat’s disease.  Germ J Ophthalmol. 1995;  4 32-36
  • 93 Schubert A, Tasman W. Familial exsudative vitreoretinopathy: surgical intervention and visual outcomes.  Graefes Arch Clin Exp Ophthalmol. 1997;  235 490-493
  • 94 Schubert H D. Structural organization of choroidal colobomas og young adult patients and mechanism of retinal detachment.  Trans Am, Ophthalmol Soc. 2005;  103 457-472
  • 95 Scott I U, Flynn H W, Azen S P. et al . Silicon oil in the repair of pediatric complex retinal detachment. A prospective, observational, multicenter study.  Ophthalmology. 1999;  106 1399-1408
  • 96 Seaber J H, Machemer R, Eliott D. et al . Long-term results of children after initally successful vitrectomy for stage V retinopathy of prematurity.  Ophthalmology. 1995;  102 199-204
  • 97 Shah P K, Narendran V, Kalpana N. et al . Anatomical and visual outcome of stages 4 and 5 retinopathy of prematurity.  Eye. 2007;  Aug 3 1-5
  • 98 Shah P K, Narendran V, Tawansy K A. et al . Intravitreal bevacizumab for post laser anterior segment ischemia in aggressive postreior retinopathy of prematurity.  Indian J Ohthalmol. 2007;  55 75-76
  • 99 Sharma T, Gopal L, Shanmugam M P. et al . Retinal detachment in Marfan syndrome.  Retina. 2002;  22 423-428
  • 100 Sheard R M, Mireskandari K, Ezra E. et al . Eye. Vitreoretinal surgery after childhood ocular trauma.  Eye. 2007;  21 793-798
  • 101 Shields J A, Shields C L, Honavar S G. et al . Classification and management of Coats disease: The 2000 Proctor lecture.  Am J Ophthalmol. 2001;  131 572-583
  • 102 Shields J A, Shields C. Review: Coats disease. The 2001 LuEsther T. Mertz lecture.  Retina. 2002;  22 80-91
  • 103 Sikkink S K, Biswas S, Parry N RA. et al . X-linked retinoschisis: an update.  J Med Genet. 2007;  44 225-232
  • 104 Snead M P. Hereditäre Vitreoretinopathy.  Eye. 1996;  10 653-663
  • 105 Snead M P, Yates J R. Clinical and molecular genetics of Stickler syndrome.  J Med Genet. 1999;  36 353-359
  • 106 Spiegel D, Nasemann J, Nawrocki J. et al . Severe ocular trauma managed with primary pars plana vitrectomy and silicone oil.  Retina. 1997;  17 275-285
  • 107 Sun Y, Jain A, Moshfeghi D M. Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium.  Graefe’s Arch Clin Exp Ophthalmol. 2007;  245 1387-1388
  • 108 Travassos A, Teixeira S, Ferreira P. et al . Intravitreal Bevacizumab in aggressive posterior retinopathy of prematurity.  Ophthalmic Surg Lasers Imaging. 2007;  38 233-237
  • 109 The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity . II. Calssification of retinal detachment.  Arch Ophthalmol. 1987;  105 906-912
  • 110 Trese M. Scleral buckling for retinopathy of prematurity.  Ophthalmology. 1994;  101 23-26
  • 111 Tugal-Tutkun I, Havrlikova K, Power W J. et al . Changing patterns in Uveitis of child-hood.  Ophthalmology. 1996;  103 375-383
  • 112 Wang N K, Tsai C H, Chen Y P. et al . Pediatric rhegmatogenous retinal detachment in East Asians.  Ophthalmology. 2005;  112 1891-1896
  • 113 Wang N K, Chen K P, Yeung L. et al . Traumatic pediatric retinal detachment following open globe injury.  Ophthalmologica. 2007;  221 255-263
  • 114 Weinberg D V, Lyon A T, Greenwald M J. et al . Rhegmatogenous retinal detachments in children.  Ophthalmology. 2003;  110 1708-1713
  • 115 Wheatley H M, Traboulsi EI Flowers B E, Maumenee I CH. et al . Immunhistochemical localisation of fibrillen in human ocular tissues.  Arch Ophthalmol. 1995;  113 103-109
  • 116 Wiedemann P, Leinung C, Hilgers R D. et al . Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy.  Greafes Arch Clin Exp Ophthalmology. 1991;  229 150-152
  • 117 Yokoyama T, Kato T, Minamoto A. et al . Characteristics and surgical outcomes of pediatric retinal detachment.  Eye. 2004;  18 889-892
  • 118 Yoshizumi M O, Kreiger A E, Lewis H. et al . Vitrectomy techniques in late-stage Coats’like exsudative detachment.  Doc Ophthalmol. 1995;  90 387-394

PD Dr. Petra Meier

Universität Leipzig, Klinik und Poliklinik für Augenheilkunde

Liebigstr. 10 – 14

04103 Leipzig

Telefon: ++ 49/3 41/9 72 15 67

Fax: ++ 49/3 41/9 72 16 59

eMail: petra.meier@medizin.uni-leipzig.de

    >